For two years, she had battled the company to cover blood plasma infusions called intravenous immunoglobulin, or IVIG. The treatment has been shown, in some cases, to improve symptoms associated with ...
"I was fighting to survive": Patients still struggle with preauthorization despite promise of reform
Last summer, the Trump administration announced a voluntary pledge by health insurers to reform prior authorization, but patient advocates and medical providers remain skeptical.
AOM Infusion ("AOM"), a leading specialty infusion pharmacy and provider, today announced it has joined Kedrion Biopharma’s ...
The NHS is celebrating one year since patients first began receiving medicines made from UK plasma.
At a health plan for private school employees in Pennsylvania, pharmacy expenses are expected to hit 30% of total healthcare costs this year. Drug costs have risen faster than medical expenses since ...
Kelly for KFF Health News) March 14, 2026 - By Lauren Sausser - Sheldon Ekirch is used to being disappointed by her health insurance company. That’s why Ekirch, 31, of Henrico, Virginia, was stunned ...
A national distribution network with robust reach enables broad access to QIVIGY across specialty pharmacies, infusion centers, hospitals, and other sites ...
Acute necrotizing encephalopathy (ANE) is a rare but life-threatening pediatric neurologic disorder characterized by rapid ...
A decade ago, Doug Upton was the picture of strength as a U.S. Marine Corps officer stationed in Jordan. But in 2016, subtle warning signs emerged, indicating something wasn’t quite right. “My legs ...
This year’s Rare Disease Day event Feb. 27 at the Jacobs School of Medicine and Biomedical Sciences focused on updates in research and diagnostics, and advancements in treatment.
Universal month-3 NGF MRD negativity (10⁻⁵) followed short-course VRd or daratumumab-based induction and single-infusion YK-hBCMA BB-002, despite high-risk biology and frailty representation. Depth of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results